ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tenax Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TENX
New York, New York--(Newsfile Corp. - November 8, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tenax Therapeutics, Inc. (NASDAQ: TENX) between November 13, 2023 and August 7, 2026, both dates inclusive (the "Class Period"), of the important December 28, 2026 lead plaintiff deadline.SO WHAT: If you purchased Tenax securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through...